N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

C93H88N26O6 — CID 157412300

IUPACN-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESCN1CCN(c2ncccc2NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)CC1.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12.O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12
InChIInChI=1S/C26H27N7O2.C23H23N7O.C22H18N6O2.C22H20N6O/c34-26(29-20-4-6-24(28-16-20)33-7-1-2-8-33)25-22-14-18(3-5-23(22)30-31-25)19-13-21(17-27-15-19)32-9-11-35-12-10-32;1-29-10-12-30(13-11-29)22-20(5-3-9-25-22)26-23(31)21-18-14-16(6-7-19(18)27-28-21)17-4-2-8-24-15-17;29-21(13-3-4-13)25-18-7-9-24-12-19(18)26-22(30)20-16-10-14(5-6-17(16)27-28-20)15-2-1-8-23-11-15;29-22(25-17-6-8-20(24-14-17)28-10-1-2-11-28)21-18-12-15(5-7-19(18)26-27-21)16-4-3-9-23-13-16/h3-6,13-17H,1-2,7-12H2,(H,29,34)(H,30,31);2-9,14-15H,10-13H2,1H3,(H,26,31)(H,27,28);1-2,5-13H,3-4H2,(H,26,30)(H,27,28)(H,24,25,29);3-9,12-14H,1-2,10-11H2,(H,25,29)(H,26,27)
InChIKeyBOKSULSFWMNQRN-UHFFFAOYSA-N
MW1665.90 g/mol
LogP14.23
Rot. Bonds18

About N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (PubChem CID 157412300) has the molecular formula C93H88N26O6 and a molecular weight of 1665.90 g/mol. Its IUPAC name is N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.

Molecular Properties

Compound NameN-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
PubChem CID157412300
Molecular FormulaC93H88N26O6
Molecular Weight1665.90 g/mol
Exact Mass1664.74
IUPAC NameN-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESCN1CCN(c2ncccc2NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)CC1.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12.O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12
InChIInChI=1S/C26H27N7O2.C23H23N7O.C22H18N6O2.C22H20N6O/c34-26(29-20-4-6-24(28-16-20)33-7-1-2-8-33)25-22-14-18(3-5-23(22)30-31-25)19-13-21(17-27-15-19)32-9-11-35-12-10-32;1-29-10-12-30(13-11-29)22-20(5-3-9-25-22)26-23(31)21-18-14-16(6-7-19(18)27-28-21)17-4-2-8-24-15-17;29-21(13-3-4-13)25-18-7-9-24-12-19(18)26-22(30)20-16-10-14(5-6-17(16)27-28-20)15-2-1-8-23-11-15;29-22(25-17-6-8-20(24-14-17)28-10-1-2-11-28)21-18-12-15(5-7-19(18)26-27-21)16-4-3-9-23-13-16/h3-6,13-17H,1-2,7-12H2,(H,29,34)(H,30,31);2-9,14-15H,10-13H2,1H3,(H,26,31)(H,27,28);1-2,5-13H,3-4H2,(H,26,30)(H,27,28)(H,24,25,29);3-9,12-14H,1-2,10-11H2,(H,25,29)(H,26,27)
InChIKeyBOKSULSFWMNQRN-UHFFFAOYSA-N
XLogP14.23
TPSA388.77 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds18
Heavy Atoms125
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001665.90
LogP ≤ 514.23
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Analyze N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The IUPAC name of N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (CID 157412300) is N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.
What is the SMILES notation for N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The canonical SMILES for N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is CN1CCN(c2ncccc2NC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)CC1.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(N4CCOCC4)c3)cc12.O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12.
What is the InChIKey of N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The InChIKey is BOKSULSFWMNQRN-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27N7O2.C23H23N7O.C22H18N6O2.C22H20N6O/c34-26(29-20-4-6-24(28-16-20)33-7-1-2-8-33)25-22-14-18(3-5-23(22)30-31-25)19-13-21(17-27-15-19)32-9-11-35-12-10-32;1-29-10-12-30(13-11-29)22-20(5-3-9-25-22)26-23(31)21-18-14-16(6-7-19(18)27-28-21)17-4-2-8-24-15-17;29-21(13-3-4-13)25-18-7-9-24-12-19(18)26-22(30)20-16-10-14(5-6-17(16)27-28-20)15-2-1-8-23-11-15;29-22(25-17-6-8-20(24-14-17)28-10-1-2-11-28)21-18-12-15(5-7-19(18)26-27-21)16-4-3-9-23-13-16/h3-6,13-17H,1-2,7-12H2,(H,29,34)(H,30,31);2-9,14-15H,10-13H2,1H3,(H,26,31)(H,27,28);1-2,5-13H,3-4H2,(H,26,30)(H,27,28)(H,24,25,29);3-9,12-14H,1-2,10-11H2,(H,25,29)(H,26,27).
What are the key properties of N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide has a molecular weight of 1665.90 g/mol, XLogP of 14.23, 18 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(cyclopropanecarbonylamino)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;5-pyridin-3-yl-N-(6-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is sourced from PubChem (CID 157412300), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).